PSPeptides supplies research-grade GHK-Cu in injectable lyophilized form, oral tablet form, and within the GLOW and KLOW blends at 99%+ verified purity with batch-specific third-party HPLC testing and US-based manufacturing

These represent reported experience rather than validated clinical practice: Typical Reported Range Starting dose: 510 mg orally per day Common maintenance: 1020 mg per day Exploratory high-end: 2030 mg per day in some reports Most reports cluster around 1015 mg daily as a "standard" dose Dosing frequency varies: some take it once daily, others split into two doses Timeline to Perceived Effects Anecdotal reports suggest a variable timeline: Some users report subjective effects (improved mood, mental clarity) within 37 days Others report delayed effects after 24 weeks Some users report no discernible effects even at higher doses Effects are highly individual and may depend on baseline cognition, genetics, health status, and other factors Why 10mg Is a Conservative Starting Point The 10 mg tablet format has become the de facto standard in community use
Here is why we do not use those sources, and why you should not either
Starting a new peptide can trigger hypervigilance
One unit on a 1 ml (100-unit) insulin syringe equals 0.2 mg of MOTS-c
The Science Cagrilintide is a long-acting analogue of amylin, a hormone naturally released by the pancreas alongside insulin after meals